Dymista and Thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia is reported as a side effect among people who take Dymista (azelastine hydrochloride; fluticasone propionate), especially for people who are female, 60+ old, also take Tylenol, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Thrombocytopenia when taking Dymista. It is created by eHealthMe based on reports of 4,296 people who have side effects when taking Dymista from the FDA, and is updated regularly.

What is Dymista?

Dymista has active ingredients of azelastine hydrochloride; fluticasone propionate. It is often used in allergies. eHealthMe is studying from 4,407 Dymista users. Check the latest studies of Dymista.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,791 drugs and 4,873 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.

On Aug, 05, 2026

4,296 people reported to have side effects when taking Dymista.
Among them, 21 people (0.49%) have Thrombocytopenia.

Among these 21 people:

What is the gender of people who have Thrombocytopenia when taking Dymista? *

female: 60 %
male: 40 %

What is the age of people who have Thrombocytopenia when taking Dymista? *

What are other drugs people take besides Dymista? *

What are other side effects people have besides Thrombocytopenia? *

Pneumonia: 11 people, 52.38%
Drug Ineffective: 9 people, 42.86%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 28.57%
Blood Folate Decreased: 6 people, 28.57%
Insomnia (sleeplessness): 4 people, 19.05%
Diarrhea: 4 people, 19.05%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 14.29%
Disease Progression: 3 people, 14.29%
Dry Mouth: 3 people, 14.29%
Hypotension (abnormally low blood pressure): 3 people, 14.29%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 19.05%
Multiple Myeloma (cancer of the plasma cells): 4 people, 19.05%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Depression: 2 people, 9.52%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 9.52%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 9.52%
Pain: 2 people, 9.52%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
High Blood Cholesterol: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Dymista and have Thrombocytopenia?

- Check whether Thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dymista:

Dymista (4,407 reports)

Thrombocytopenia treatments and more:

Thrombocytopenia (285,083 reports)

How severe was Thrombocytopenia and when was it recovered:

Thrombocytopenia in Dymista

Expand to all the drugs that have ingredients of azelastine hydrochloride; fluticasone propionate:

Thrombocytopenia and drugs with ingredients of azelastine hydrochloride; fluticasone propionate (12 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dymista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (2,791 drugs)

Browse all the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,873 conditions)

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride; fluticasone propionate (the active ingredients of Dymista) and Dymista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.